John Paul Waymack
Kitov Pharmaceuticals Ltd
Dr. Waymack is one of the founders of Kitov. He has served as the chairman of Kitov’s board of directors and as Chief Medical Officer, in which capacity he has been responsible for its medical operations, since 2013. Dr. Waymack has over 20 years of experience in the biopharma field. Dr. Waymack is a former academic transplant surgeon and FDA Medical Officer, with over 20 years of experience in drug development as a consultant for major pharmaceutical companies, including Pfizer, Roche, Pharmacia, Warner Lambert and Searle. During his 10-year academic career, Dr. Waymack published over 100 scientific essays, mainly in the fields of prostaglandins and immunology. Dr. Waymack was also an Associate Professor of Surgery at the University of Texas Medical Branch and at the University of Medicine and Dentistry of New Jersey. Dr. Waymack serves as a member of the board of directors and board of advisors for various public and private healthcare corporations, including member of the board of advisors for the publicly-traded Moleculin Corporation.